461 results match your criteria Bulletin on the rheumatic diseases[Journal]


Getting to the heart of the matter in systemic lupus and rheumatoid arthritis.

Authors:
S Manzi M C Wasko

Bull Rheum Dis 2001 ;50(5):1-4

Department of Medicine, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
November 2002

The use of low-dose prednisone in the management of rheumatoid arthritis.

Authors:
S S Lim D L Conn

Bull Rheum Dis 2001 ;50(12):1-4

Emory University School of Medicine, Atlanta, GA, USA.

Low doses of prednisone are safe and effective in the management of RA. Yet, some clinicians continue to manage their RA patients with glucocorticoid doses that are too high or avoid them altogether. Glucocorticoids in low doses have proven to be very effective in suppressing the inflammation associated with RA. Read More

View Article

Download full-text PDF

Source
November 2002

Sensible approach to low back pain.

Authors:
S M Helfgott

Bull Rheum Dis 2001 ;50(3):1-4

Division of Allergy, Immunology & Rheumatology, Brigham & Women's Hospital, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
November 2002

Update on reactive arthritis.

Authors:
L H Sigal

Bull Rheum Dis 2001 ;50(4):1-4

Departments of Medicine, Pediatrics, and Molecular Genetics & Microbiology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

View Article

Download full-text PDF

Source
November 2002

An update on specific COX-2 inhibitors: the COXIBs.

Bull Rheum Dis 2001 ;50(1):1-4

Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
July 2002
1 Read

Gout basics.

Bull Rheum Dis 2001 ;50(9):1-3

Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source

Selective COX-2 inhibition.

Authors:
S Silas D O Clegg

Bull Rheum Dis 1999 ;48(2):1-4

University of Utah School of Medicine, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
June 2002
1 Read

Running and the musculoskeletal system.

Bull Rheum Dis 2001 ;50(11):1-4

Department of Medicine, Saint Barnabas Medical Center, Livingston, NJ, USA.

View Article

Download full-text PDF

Source
December 2001

Pain and the cervical spine.

Authors:
J Hardin

Bull Rheum Dis 2001 ;50(10):1-4

Department of Medicine, University of South Alabama, Mobile, AL, USA.

Persistent neck symptoms following flexion-extension type injuries are common and may respond to early mobilization. Cervical degenerative disc and joint disease probably account for most chronic neck-related problems. Most often symptoms result from compression of neural structures, especially nerve roots. Read More

View Article

Download full-text PDF

Source
December 2001
3 Reads

Polymyalgia rheumatica revisited.

Authors:
M D Cohen A Abril

Bull Rheum Dis 2001 ;50(8):1-4

Division of Rheumatology, Mayo Clinic, Jacksonville, FL, USA.

View Article

Download full-text PDF

Source
October 2001

Glucosamine and chondroitin for osteoarthritis?

Authors:
T McAlindon

Bull Rheum Dis 2001 Jul;50(7):1-4

Arthritis Center, Boston University Medical Center, Boston, MA, USA.

The current body of evidence currently supports modest efficacy for glucosamine and chondroitin in the treatment of OA symptoms. The products are safe and could play a valuable role in the management of this disorder. Nevertheless, further independent studies are needed to confirm these findings and to determine the clinical applicability of these compounds. Read More

View Article

Download full-text PDF

Source
July 2001
3 Reads

Sports, exercise, and arthritis.

Authors:
B Clyman

Bull Rheum Dis 2001 ;50(6):1-3

Department of Ambulatory Care, Greater Los Angeles VA Medical System, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source

The genetics of ankylosing spondylitis.

Authors:
J D Reveille

Bull Rheum Dis 2001 ;50(2):2-3

Division of Rheumatology and Clinical Immunogenetics, University of Texas, Houston Health Science Center, Houston, TX, USA.

View Article

Download full-text PDF

Source

Genetics and rheumatic diseases: rheumatoid arthritis and ankylosing spondylitis. The genetics of rheumatoid arthritis.

Authors:
P K Gregersen

Bull Rheum Dis 2001 ;50(2):1-2

Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, NY, USA.

View Article

Download full-text PDF

Source

Use of etanercept in children.

Bull Rheum Dis 2000 ;49(12):1-4

William S. Rowe Division of Rheumatology, Children's Hospital Medical Center, University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, OH, USA.

View Article

Download full-text PDF

Source

Musculoskeletal manifestations of thyroid disease.

Authors:
J Waltuck

Bull Rheum Dis 2000 ;49(11):1-3

Rheumatology Division, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source

Update on management of scleroderma.

Authors:
S D Sule F M Wigley

Bull Rheum Dis 2000 ;49(10):1-4

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source

Systemic lupus erythematosus: women's health issues.

Authors:
M Petri

Bull Rheum Dis 2000 ;49(8):1-3

Johns Hopkins University, School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source

Sex and arthritis.

Bull Rheum Dis 2000 Jul;49(7):1-4

Saint Barnabas Health Care System, Livingston, NJ, USA.

View Article

Download full-text PDF

Source
July 2000
1 Read

Adult-onset Still's disease.

Authors:
J J Cush

Bull Rheum Dis 2000 ;49(6):1-4

Presbyterian Hospital of Dallas, University of Texas Southwestern Medical Center at Dallas, USA.

View Article

Download full-text PDF

Source
December 2000

Approach to the patient with suspected vasculitis.

Authors:
M D Cohen D L Conn

Bull Rheum Dis 1999 ;48(12):1-4

Division of Rheumatology, Mayo Clinic, Jacksonville, FL, USA.

By taking a careful patient history, conducting a thorough physical examination, knowing the clinical features of vasculitis, and using selected laboratory tests, the physician can diagnosis vasculitis tentatively. Recognizing the pattern of organ involvement provides a clue to the type of vasculitis present. Serologic laboratory tests for ANCAs or hepatitis B or C may help confirm the presence of the underlying vasculitis, and a definitive diagnosis can be confirmed by a biopsy of involved tissue or by angiography. Read More

View Article

Download full-text PDF

Source

Update on the treatment of Wegener's granulomatosis.

Bull Rheum Dis 1999 ;48(11):1-4

Department of Neurology, Washington University Hospitals, St. Louis, MO, USA.

Mortality due to WG has been significantly decreased by cytotoxic therapy with cyclophosphamide and glucocorticoids. Several studies have addressed different treatment regimens, particularly different maintenance regimens, in order to reduce the potential for cyclophosphamide-induced toxicity. Relapse may be precipitated by the chronic carrier-state of S aureus in the nasopharynx, and is sometimes heralded by rising c-ANCA titers. Read More

View Article

Download full-text PDF

Source

Common painful foot syndromes.

Bull Rheum Dis 1999 ;48(10):1-4

Department of Medicine, Saint Barnabas Medical Center, Livingston, NJ, USA.

The prevalence of foot problems in the general population is 10%, and in the elderly it ranges from 53% to 95%. Proximal plantar fasciitis is the most common cause of painful feet in clinical practice, and is twice as common among women as among men. Metatarsalgia is probably the most common cause of foot pain among middle-aged women. Read More

View Article

Download full-text PDF

Source

Lupus for the non-rheumatologist.

Authors:
D J Wallace

Bull Rheum Dis 1999 ;48(9):1-4

Cedars-Sinai/UCLA School of Medicine, USA.

View Article

Download full-text PDF

Source
February 2000

Leflunomide for the treatment of rheumatoid arthritis.

Bull Rheum Dis 1999 ;48(8):1-4

Department of Medicine, Vanderbilt University, Nashville, TN, USA.

Leflunomide treatment appears to offer an alternative to methotrexate and sulfasalazine and is a welcome addition to the therapeutic armamentarium for treating active RA. Leflunomide treatment for more than 12 months results in clinically meaningful improvements in disease-specific measures of physical function. The phase 3 trials have shown leflunomide to be as effective as methotrexate and sulfasalazine and an option for initial DMARD therapy. Read More

View Article

Download full-text PDF

Source
January 2000

The allure of alternative therapies.

Authors:
D L Conn

Bull Rheum Dis 1999 ;48(7)

View Article

Download full-text PDF

Source

Alternative treatments and rheumatic diseases.

Bull Rheum Dis 1999 ;48(7):1-3

Division of Rheumatology, Grady Health System, Atlanta, GA, USA.

View Article

Download full-text PDF

Source

Osteoporosis: diagnosis, prevention, and treatment of established disease.

Authors:
M B Dunlop N E Lane

Bull Rheum Dis 1999 ;48(6):1-4

Rosalind Russell Arthritis Research Laboratory, San Francisco General Hospital, CA, USA.

View Article

Download full-text PDF

Source
November 1999

Update on fibromyalgia syndrome.

Bull Rheum Dis 1999 ;48(5):1-4

Division of Rheumatology, Cedars-Sinai/UCLA School of Medicine, USA.

View Article

Download full-text PDF

Source
November 1999

Lyme disease and the Lyme disease vaccines.

Authors:
L H Sigal

Bull Rheum Dis 1999 Apr;48(4):1-4

University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, USA.

Both OspA vaccines, with or without adjuvant, are effective and safe. People must receive repeated doses of the vaccine, however, to receive effective protection. If the vaccines are to be part of a Lyme disease prevention strategy, doctors and patients must pay attention to booster shot timing. Read More

View Article

Download full-text PDF

Source

Tumor necrosis factor inhibitors for rheumatoid arthritis.

Bull Rheum Dis 1999 ;48(3):1-4

Department of Medicine, University of Alabama at Birmingham, USA.

Tumor necrosis factor antagonists such as infliximab and etanercept represent a new and powerful approach to managing RA. In studies published to date, TNF antagonists appear to be safe and effective agents for short-term therapeutic use in RA. Defining when in the course of RA to use TNF antagonists and determining the effectiveness of combinations of these biologic agents with DMARDs or other cytokine antagonists are areas of current and future studies. Read More

View Article

Download full-text PDF

Source

Why is the ANA result positive?

Bull Rheum Dis 1999 Jan;48(1):1-4

Arthritis and Rheumatism Branch, National Institutes of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA.

Antinuclear antibody testing is a useful way to confirm the diagnosis of lupus when the clinical suspicion is high, or to exclude it in cases when SLE is in the differential diagnosis but the likelihood of it is low to moderate. Because the test is very sensitive and yet not specific for lupus, an inappropriately ordered ANA test with a positive result can cause diagnostic confusion and unnecessary anxiety for the patient and the physician. Read More

View Article

Download full-text PDF

Source
January 1999

Aggressive treatment of early rheumatoid arthritis to prevent joint damage.

Authors:
T Pincus

Bull Rheum Dis 1998 Dec;47(8):2-7

Vanderbilt University School of Medicine, Nashville, TN, USA.

View Article

Download full-text PDF

Source
December 1998
1 Read

Hyaluronic acid treatment (viscosupplementation) for OA of the knee.

Authors:
M D Cohen

Bull Rheum Dis 1998 Nov;47(7):4-7

Mayo Clinic, Jacksonville, FL, USA.

Viscosupplementation may be useful in the treatment of OA of the knee when other medical forms of therapy are contraindicated, toxic, or have failed. It may have a role in managing the patient with moderate to severe OA of the knee before considering total knee arthroplasty (Table 2). Viscosupplementation or medical treatment does not replace the need for thigh muscle strengthening or for overweight patients to lose weight. Read More

View Article

Download full-text PDF

Source
November 1998
1 Read

Preventing knee and hip osteoarthritis.

Authors:
D T Felson

Bull Rheum Dis 1998 Nov;47(7):1-4

Boston University Arthritis Center, MA, USA.

View Article

Download full-text PDF

Source
November 1998

Antineutrophil cytoplasmic antibodies.

Bull Rheum Dis 1998 Oct;47(6):5-8

Cleveland Clinic Foundation, OH, USA.

View Article

Download full-text PDF

Source
October 1998

When it's not a rheumatic disease.

Bull Rheum Dis 1998 Oct;47(6):2-4

Saint Barnabas Medical Center, Livingston, New Jersey, USA.

View Article

Download full-text PDF

Source
October 1998

When should you consider vasculitis?

Authors:
D L Conn

Bull Rheum Dis 1998 Oct;47(6):1-2

View Article

Download full-text PDF

Source
October 1998

The eye and rheumatic disease.

Authors:
D A Jabs

Bull Rheum Dis 1998 Aug;47(5):5-10

Johns Hopkins University School of Medicine, Balitmore, MD, USA.

View Article

Download full-text PDF

Source
August 1998
4 Reads

Use of methotrexate in children.

Bull Rheum Dis 1998 Aug;47(5):1-5

Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Methotrexate continues to be the safest and most efficacious second-line drug for the treatment of JRA. In addition, it is useful in other inflammatory conditions in children. Careful education is necessary, particularly with regard to the importance of laboratory tests and the avoidance of comorbidity such as pregnancy and alcohol-induced liver injury. Read More

View Article

Download full-text PDF

Source

Joint replacement surgery: preoperative management.

Bull Rheum Dis 1998 Jun;47(4):5-8

Birmingham VA Medical Center, AL, USA.

View Article

Download full-text PDF

Source

Diagnosis and management of complicated gout.

Bull Rheum Dis 1998 Jun;47(4):2-5

Division of Rheumatology, Allergy, and Immunology, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.

Although a diagnosis of gout can be confirmed by the presence of monosodium urate crystals in synovial fluid, arriving at the suspected diagnosis and managing the disease can be a challenge for primary care physicians and specialists alike. Symptoms of gout can mimic other forms of inflammatory arthritis such as rheumatoid arthritis, pseudogout, or septic arthritis. Treatment can be complicated by the patient's need for drugs that contribute to hyperuricemia. Read More

View Article

Download full-text PDF

Source
June 1998
1 Read

Parvovirus: a review.

Bull Rheum Dis 1998 May;47(3):4-9

Cleveland Clinic Children's Hospital, OH, USA.

Infections caused by human parvovirus B19 result in a variety of clinical manifestations, the severity of which depends on the immune and hematologic status of the host. Arthropathy is known to occur in children and adults with acute parvovirus B19 infection. In adults, the arthropathy is common and is usually brief and self-limited, although a chronic arthropathy due to HPV B19 infections can occur rarely. Read More

View Article

Download full-text PDF

Source

Case management study: polyarthritis with fever.

Bull Rheum Dis 1998 May;47(3):1-4

Saint Barnabas Medical Center, Livingston, NJ, USA.

In most cases, a thorough initial evaluation will reveal the cause of fever and polyarthritis. However, in some patients the initial diagnosis may be unclear and, as time passes, the characteristic clinical patterns emerge. Recurrent attacks are suggestive of other conditions such as crystal-induced arthritis, Lyme disease, and Mediterranean fever. Read More

View Article

Download full-text PDF

Source
May 1998
1 Read

Nonmedicinal therapies for osteoarthritis.

Authors:
D T Felson

Bull Rheum Dis 1998 Apr;47(2):5-7

Boston University School of Medicine, MA, USA.

Given the modest efficacy of medicinal therapy for OA, nonpharmacologic therapy is popular. Convincing evidence exists to support the efficacy of exercise and muscle strengthening for patients with knee OA. Weight loss is likely to be effective, as are some types of biomechanical alterations, possibly including elastic knee supports and the use of canes and crutches. Read More

View Article

Download full-text PDF

Source

Arthritis and hepatitis.

Authors:
J Duffy

Bull Rheum Dis 1998 Apr;47(2):1-5

Mayo Clinic, Rochester, MN, USA.

Arthritis has a fascinating relationship with hepatitis of diverse origins. Either condition can predominate and the correct diagnosis may be elusive, especially in the early stages. Humoral autoimmune mechanisms appear to serve as a bridge connecting the two target organs, whether the syndromes are caused by viral infections or unspecified etiologies. Read More

View Article

Download full-text PDF

Source

Gonococcal arthritis.

Authors:
M Cohen

Bull Rheum Dis 1998 Feb;47(1):4-6

Division of Rheumatology, Mayo Clinic Jacksonville, FL, USA.

View Article

Download full-text PDF

Source
February 1998

Case management study: osteoporotic vertebral compression fracture.

Bull Rheum Dis 1998 Feb;47(1):1-2

Mayo Graduate School of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
February 1998
2 Reads

Helicobacter pylori and nonsteroidal antiinflammatory drugs: partners in crime?

Bull Rheum Dis 1997 Dec;46(8):6-8

Division of Gastroenterology/Nutrition, Hospital for Sick Children, Toronto, Ontario.

View Article

Download full-text PDF

Source
December 1997

Human immunodeficiency virus infection and rheumatic disease.

Authors:
L H Calabrese

Bull Rheum Dis 1997 Dec;46(8):2-5

Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, OH, USA.

View Article

Download full-text PDF

Source
December 1997